Market Overview

U.S. Physical Therapy Announces First Quarter 2017 Select Preliminary Operating and Financial Results


U.S. Physical Therapy, Inc. ("USPH") (NYSE:USPH) is a national operator
of outpatient physical therapy clinics. The Company today reported
select operating and financial results for the first quarter ended March
31, 2017. The below financial information is preliminary and unaudited,
and subject to adjustment based on the Company's final review.

First Quarter 2017 Compared to First Quarter
2016 - Select Preliminary Operating and Financial Results

  • Total net revenues increased 12.3% from $86.9 million in the 2016
    period to $97.6 million in the 2017 period, primarily due to a 10.1%
    increase in net patient revenues from the physical therapy operations,
    higher revenues from management contracts due to an increase in the
    number of facilities managed by the Company and one month of revenues
    from the workforce performance solutions business acquired in March
  • Net patient revenues from physical therapy operations increased
    approximately $8.6 million to $93.7 million in the 2017 period from
    $85.0 million in the 2016 period due to an increase in total patient
    visits of 10.3% from 808,000 to 892,000 partially offset by a $0.18
    decrease in average net patient revenue per visit to $105.04 from
    $105.22. Revenues from management contracts and other, excluding the
    workforce performance solutions business, was $2.4 million.
  • The revenues from the recently acquired workforce performance
    solutions business was $1.5 million for the month of March 2017.
  • Average physical therapy patient visits per day per clinic increased
    to 25.2 in the first quarter of 2017 from 24.7 in the 2016 period.
  • Same store revenues and visits increased slightly for de novo and
    acquired clinics open for one year or more. The same store net rate
    per visit was flat.

Other Financial and Operational Information

  • On January 3, 2017, the Company acquired a 70% interest in a physical
    therapy practice that owns and operates 17 clinics and manages an
    additional 8 clinics.
  • Effective March 1, 2017, the Company acquired a 55% interest in a
    leading provider of workforce performance solutions. Services provided
    include onsite injury prevention and rehabilitation, performance
    optimization and ergonomic assessments.
  • The aggregate consideration paid for the two acquisitions was $18.0
    million of which $17.1 million was paid in cash and $0.9 million in
    notes payable.
  • As of March 31, 2017 total patient accounts receivable were $43.2
    million, net of $1.9 million of allowance for doubtful accounts.
  • The average age of the Company's accounts receivables was 39 days at
    March 31, 2017.
  • Borrowings under the Company's amended credit agreement totaled $58.0
    million at March 31, 2017.
  • Notes payable to selling shareholders as of March 31, 2017 were $6.0
  • As of March 31, 2017, the Company's cash balance was $25.2 million.
  • As of the end of the first quarter of 2017, net debt (third party debt
    minus cash) was $38.8 million.

Management's Comments

Chris Reading, Chief Executive Officer, said, "Business revenues and
patient volume remains strong. Development activities, both de novo and
acquisition related, are very healthy. Additionally, we have added to
our team and resources recently to further strengthen our development
related activities. While we continue to move our Company's operations
forward, we are also working diligently to complete the steps necessary
to become current in our filings with the Securities and Exchange
Commission. Thank you, our shareholders, for your continued support."

Accounting Correction for Redeemable
Non-Controlling Interests and Restatement of Prior Period Financial

As previously disclosed on March 17, 2017, the Company filed a Form
12b-25, Notification of Late Filing, with the Securities and Exchange
Commission ("SEC") regarding the delayed filing of the Annual Report on
Form 10-K for the fiscal year ended December 31, 2016 (the "2016 Form
10-K") due to management's need for additional time to complete its
review of the appropriate accounting treatment for redeemable
non-controlling interests of its acquired partnerships. On March 31,
2017, the Company further announced that it was working to be in a
position to file its 2016 Form 10-K with the SEC as soon as possible in
April 2017. On April 28, 2017, the Company disclosed that it did not
meet its target of filing the 2016 Form 10-K in April 2017 and continues
to work diligently to complete the preparation of its consolidated
financial statements in order to file both its 2016 Form 10-K and its
Quarterly Report on Form 10-Q for the quarter ended March 31, 2017 as
soon as is possible.

Forward-Looking Statements

This press release contains statements that are considered to be
forward-looking within the meaning under Section 21E of the Securities
Exchange Act of 1934, as amended. These

statements contain forward-looking information relating to the financial
condition, results of operations, plans, objectives, future performance
and business of our Company. These statements (often using words such as
"believes", "expects", "intends", "plans", "appear", "should" and
similar words) involve risks and uncertainties that could cause actual
results to differ materially from those we expect. Included among such
statements may be those relating to new clinics, availability of
personnel and the reimbursement environment. The forward-looking
statements are based on our current views and assumptions and actual
results could differ materially from those anticipated in such
forward-looking statements as a result of certain risks, uncertainties,
and factors, which include, but are not limited to:

  • the risk that the review for the correction in accounting method for
    redeemable non-controlling interests could result in the determination
    that the effect of the matters under review are materially greater or
    lesser than the Company currently believes;
  • the risk that the correction in the accounting method for redeemable
    non-controlling interests could adversely affect the Company's ability
    to make timely filings with the Securities and Exchange Commission;
  • the risk of damage to the Company's business and reputation arising
    from the correction in accounting method for redeemable
    non-controlling interests, and potential claims or proceedings
    relating to such matters;
  • changes as the result of government enacted national healthcare reform;
  • changes in Medicare guidelines and reimbursement or failure of our
    clinics to maintain their Medicare certification status;
  • revenues we receive from Medicare and Medicaid being subject to
    potential retroactive reduction;
  • business and regulatory conditions including federal and state
  • governmental and other third party payor investigations and audits;
  • compliance with federal and state laws and regulations relating to the
    privacy of individually identifiable patient information, and
    associated fines and penalties for failure to comply;
  • possible legal actions; which could subject us to increased operating
    costs and uninsured liabilities;
  • changes in reimbursement rates or payment methods from third party
    payors including government agencies and deductibles and co-pays owed
    by patients;
  • revenues and earnings expectations;
  • general economic conditions;
  • availability and cost of qualified physical and occupational
  • personnel productivity and retaining personnel;
  • competitive, economic or reimbursement conditions in our markets which
    may require us to reorganize or close certain operations and thereby
    incur losses and/or closure costs including the possible write-down or
    write-off of goodwill and other intangible assets;
  • acquisitions, purchase of non-controlling interests (minority
    interests) and the successful integration of the operations of the
    acquired businesses;
  • maintaining adequate internal controls;
  • maintaining necessary insurance coverage;
  • availability, terms, and use of capital; and
  • weather and other seasonal factors.

Many factors are beyond our control. Given these uncertainties, you
should not place undue reliance on our forward-looking statements.
Please see our periodic reports filed with the Securities and Exchange
Commission for more information on these factors. Our forward-looking
statements represent our estimates and assumptions only as of the date
of this press release. Except as required by law, we are under no
obligation to update any forward-looking statement, regardless of the
reason the statement is no longer applicable.

About U.S. Physical Therapy, Inc.

Founded in 1990, U.S. Physical Therapy, Inc. operates 557 outpatient
physical and occupational therapy clinics in 42 states. The Company's
clinics provide preventative and post-operative care for a variety of
orthopedic-related disorders and sports-related injuries, treatment for
neurologically-related injuries and rehabilitation of injured workers.
Besides owning and operating clinics, the Company manages 30 physical
therapy facilities for third parties, including hospitals and physician
groups. The Company also provides onsite services for clients' employees
including injury prevention, rehabilitation, ergonomic assessments and
performance optimization.

More information about U.S. Physical Therapy, Inc. is available at
The information included on that website is not incorporated into this
press release.

View Comments and Join the Discussion!